Neuberger Berman Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.9M | Sell |
93,496
-21,707
| -19% | -$7.39M | 0.02% | 570 |
|
|
2025
Q4 | $45.8M | Sell |
115,203
-15,341
| -12% | -$6.79M | 0.03% | 487 |
|
|
2025
Q3 | $59.5M | Buy |
130,544
+31,500
| +32% | +$12.8M | 0.04% | 437 |
|
|
2025
Q2 | $32.3M | Buy |
99,044
+605
| +0.6% | +$167K | 0.02% | 533 |
|
|
2025
Q1 | $26.6M | Sell |
98,439
-11,269
| -10% | -$2.9M | 0.02% | 559 |
|
|
2024
Q4 | $25.8M | Buy |
109,708
+3,511
| +3% | +$923K | 0.02% | 596 |
|
|
2024
Q3 | $29.2M | Buy |
106,197
+10,789
| +11% | +$2.81M | 0.02% | 562 |
|
|
2024
Q2 | $23.2M | Buy |
95,408
+4,058
| +4% | +$641K | 0.02% | 604 |
|
|
2024
Q1 | $13.7M | Buy |
91,350
+19,686
| +27% | +$3.28M | 0.01% | 740 |
|
|
2023
Q4 | $13.7M | Sell |
71,664
-18,176
| -20% | -$3.1M | 0.01% | 712 |
|
|
2023
Q3 | $15.9M | Sell |
89,840
-9
| -0% | -$1.72K | 0.01% | 642 |
|
|
2023
Q2 | $17.1M | Buy |
89,849
+397
| +0.4% | +$78.7K | 0.02% | 640 |
|
|
2023
Q1 | $17.9M | Buy |
89,452
+28,682
| +47% | +$6.03M | 0.02% | 644 |
|
|
2022
Q4 | $14.4M | Buy |
60,770
+55,952
| +1,161% | +$11.9M | 0.01% | 680 |
|
|
2022
Q3 | $965K | Buy |
4,818
+123
| +3% | +$23.5K | ﹤0.01% | 1270 |
|
|
2022
Q2 | $685K | Sell |
4,695
-1,590
| -25% | -$226K | ﹤0.01% | 1404 |
|
|
2022
Q1 | $1.03M | Buy |
6,285
+2,584
| +70% | +$394K | ﹤0.01% | 1338 |
|
|
2021
Q4 | $553K | Buy |
+3,701
| New | +$688K | ﹤0.01% | 1519 |
|
|
2019
Q1 | – | Sell |
-2,871
| Closed | -$209K | – | 1514 |
|
|
2018
Q4 | $209K | Hold |
2,871
| – | – | ﹤0.01% | 1484 |
|
|
2018
Q3 | $251K | Sell |
2,871
-438
| -13% | -$44.1K | ﹤0.01% | 1489 |
|
|
2018
Q2 | $326K | Buy |
3,309
+643
| +24% | +$63.8K | ﹤0.01% | 1486 |
|
|
2018
Q1 | $318K | Hold |
2,666
| – | – | ﹤0.01% | 1456 |
|
|
2017
Q4 | $339K | Hold |
2,666
| – | – | ﹤0.01% | 1508 |
|
|
2017
Q3 | $313K | Sell |
2,666
-207
| -7% | -$17.7K | ﹤0.01% | 1404 |
|
|
2017
Q2 | $229K | Buy |
+2,873
| New | +$184K | ﹤0.01% | 1484 |
|
|
2016
Q4 | – | Sell |
-3,031
| Closed | -$205K | – | 1586 |
|
|
2016
Q3 | $205K | Buy |
+3,031
| New | +$214K | ﹤0.01% | 1516 |
|
|
2015
Q2 | – | Sell |
-4,500
| Closed | -$470K | – | 1559 |
|
|
2015
Q1 | $470K | Hold |
4,500
| – | – | ﹤0.01% | 1351 |
|
|
2014
Q4 | $436K | Hold |
4,500
| – | – | ﹤0.01% | 1380 |
|
|
2014
Q3 | $351K | Buy |
+4,500
| New | +$290K | ﹤0.01% | 1426 |
|
|
2013
Q4 | – | Sell |
-22,900
| Closed | -$1.47M | – | 1613 |
|
|
2013
Q3 | $1.47M | Buy |
+22,900
| New | +$1.14M | ﹤0.01% | 1124 |
|
Other funds holding ALNY
VPM
VCM
